Unit
- Diagnostic criteria: The DSM-5 defines tobacco use disorder as a problematic pattern of tobacco use leading to clinically significant impairment or distress, with at least two of eleven criteria met within a 12-month period. These criteria include using larger amounts over time, persistent desire to cut down, cravings, and continued use despite health problems.
- Prevalence and impact: Globally, approximately 1.3 billion people use tobacco, with smoking causing over 8 million deaths annually. In the United States, about 14% of adults smoke, with higher rates among individuals with mental illness and lower socioeconomic status. The economic burden exceeds $300 billion yearly in direct healthcare costs and lost productivity.
- Nicotine dependence model: Tobacco use disorder is primarily driven by nicotine addiction, but behavioral and social factors reinforce continued use. The biopsychosocial model explains how biological vulnerability, psychological triggers, and social environment interact to maintain the disorder.
- Stages of change: Prochaska and DiClemente's transtheoretical model describes five stages: precontemplation, contemplation, preparation, action, and maintenance. Treatment must be tailored to the individual's current stage to be effective.
- Withdrawal syndrome: Nicotine withdrawal includes irritability, anxiety, difficulty concentrating, increased appetite, and insomnia. Symptoms typically peak within 24-48 hours of cessation and can last several weeks. Understanding withdrawal helps clinicians prepare patients and manage side effects.
- Comorbidity patterns: Tobacco use disorder often co-occurs with other substance use disorders, depression, anxiety, and PTSD. These conditions can complicate treatment but also provide opportunities for integrated care.
- Health consequences: Smoking causes cancers (lung, throat, bladder), cardiovascular disease, COPD, and adverse pregnancy outcomes. Quitting at any age reduces risk, and health improvements begin within days of cessation.
- Treatment history: Modern tobacco treatment emerged in the 1970s with the first Surgeon General's report on smoking. Since then, pharmacotherapy and behavioral counseling have become standard, and treatment guidelines are updated regularly by agencies like the U.S. Public Health Service.
- Pharmacotherapy options: First-line medications for tobacco cessation include nicotine replacement therapy (patch, gum, lozenge), bupropion SR, and varenicline. These treatments double or triple quit rates compared to placebo. Clinicians should consider patient preferences, medical contraindications, and prior treatment history when selecting a pharmacotherapy regimen.
- Behavioral interventions: Evidence-based behavioral treatments include cognitive-behavioral therapy, motivational interviewing, and contingency management. These approaches help patients identify triggers, develop coping strategies, and build social support. Combining behavioral counseling with pharmacotherapy yields the highest success rates for long-term abstinence.
- Relapse prevention strategies: Most relapses occur within the first three months after quitting. Effective prevention includes identifying high-risk situations, developing alternative behaviors, and creating a relapse prevention plan. Follow-up support through phone calls, text messaging, or in-person visits can reduce the likelihood of returning to smoking.
- Special populations considerations: Treatment approaches may need adaptation for pregnant women, adolescents, individuals with mental illness, and ethnic minorities. For example, pregnant smokers should use NRT under medical supervision, while adolescents benefit from family-based interventions. Culturally tailored programs improve engagement and outcomes in diverse groups.
Terminology
- Tobacco use disorder
- A medical condition characterized by impaired control over tobacco use, cravings, and continued use despite negative consequences.
- Nicotine withdrawal
- A set of symptoms that occur after stopping or reducing nicotine use, typically including irritability, anxiety, and craving.
- Transtheoretical model
- A framework for understanding behavior change that categorizes individuals into stages of readiness.
Quick Revision
- Tobacco use disorder is diagnosed using DSM-5 criteria with 11 possible symptoms.
- About 14% of U.S. adults smoke, with significant health and economic impacts.
- The biopsychosocial model explains the interplay of biological, psychological, and social factors.
- Treatment should be matched to the patient's stage of change.
- Nicotine withdrawal symptoms are temporary and manageable.
- Comorbid mental health conditions are common and require integrated approaches.